Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Conferences

iECURE
Regional

iECURE to Present Promising Initial Data from Gene Editing Trial for Neonatal OTC Deficiency

March 17, 2025March 16, 2025 - by Timothy Alexander

PHILADELPHIA, PA — iECURE, Inc. has announced that early data from its Phase 1/2 OTC-HOPE clinical trial, evaluating the gene-editing candidate ECUR-506 for neonatal onset ornithine transcarbamylase (OTC) deficiency, will be …

iECURE to Present Promising Initial Data from Gene Editing Trial for Neonatal OTC Deficiency Read More

Universal Health Services
Regional

Universal Health Services CFO to Speak at KeyBanc Virtual Healthcare Forum

March 15, 2025March 14, 2025 - by Timothy Alexander

KING OF PRUSSIA, PA — Universal Health Services, Inc. (NYSE: UHS) has announced that Steve Filton, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at …

Universal Health Services CFO to Speak at KeyBanc Virtual Healthcare Forum Read More
Nexgel
Regional

NEXGEL CEO to Present at iAccess Alpha Virtual Investment Conference

March 14, 2025March 13, 2025 - by Timothy Alexander

LANGHORNE, PA — NEXGEL, Inc. (NASDAQ: NXGL) has announced that its Chief Executive Officer, Adam Levy, will present at the iAccess Alpha Virtual Best Ideas Spring Investment Conference 2025. The …

NEXGEL CEO to Present at iAccess Alpha Virtual Investment Conference Read More

Vishay Intertechnology
Public Companies / Technology

Vishay Intertechnology Showcases Cutting-Edge Power Electronics at APEC 2025

March 13, 2025March 12, 2025 - by Timothy Alexander

MALVERN, PA — Vishay Intertechnology, Inc. (NYSE: VSH) is set to highlight its latest advancements in power electronics at the Applied Power Electronics Conference and Exposition (APEC) 2025, taking place March …

Vishay Intertechnology Showcases Cutting-Edge Power Electronics at APEC 2025 Read More
Annovis Bio
Public Companies

Annovis Bio to Showcase Advancements at Alzheimer’s & Parkinson’s Drug Development Summit

March 13, 2025March 12, 2025 - by Timothy Alexander

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) is set to participate in the 13th Alzheimer’s & Parkinson’s Drug Development Summit, taking place March 18-20 in Boston, Massachusetts. The company will …

Annovis Bio to Showcase Advancements at Alzheimer’s & Parkinson’s Drug Development Summit Read More

Vishay Precision Group
Public Companies

Vishay Precision Group to Present at Sidoti March 2025 Small-Cap Investor Conference!

March 13, 2025March 12, 2025 - by Timothy Alexander

MALVERN, PA — Vishay Precision Group, Inc. (NYSE: VPG) has announced its participation in the Sidoti March 2025 Small-Cap Virtual Investor Conference. The presentation is scheduled for Thursday, March 19, …

Vishay Precision Group to Present at Sidoti March 2025 Small-Cap Investor Conference! Read More
National Secure Transport
Regional

Payments Industry Expert John Tucker to Speak at NECANN Boston 2025

March 12, 2025March 11, 2025 - by Timothy Alexander

PHILADELPHIA, PA — John Tucker, a seasoned leader in the payments and fintech sector with more than 18 years of experience, is set to address the New England Cannabis Convention (NECANN) …

Payments Industry Expert John Tucker to Speak at NECANN Boston 2025 Read More

Innovative Solutions & Support, Inc.
Public Companies

Innovative Solutions & Support to Present at Q1 Investor Summit 2025

March 11, 2025March 10, 2025 - by Timothy Alexander

EXTON, PA — Innovative Solutions & Support (IS&S) (NASDAQ: ISSC) has announced that its Chief Executive Officer, Shahram Askarpour, and Chief Financial Officer, Jeffrey DiGiovanni, will participate in the Q1 …

Innovative Solutions & Support to Present at Q1 Investor Summit 2025 Read More
AdaptHealth
Regional

AdaptHealth Corp. to Present at Barclays Global Healthcare Conference

March 11, 2025March 10, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — AdaptHealth Corp. (NASDAQ: AHCO) has confirmed its participation in the Barclays 27th Annual Global Healthcare Conference, scheduled to take place in Miami. The company will feature in …

AdaptHealth Corp. to Present at Barclays Global Healthcare Conference Read More
Virpax Pharmaceuticals
Public Companies

Virpax Pharmaceuticals to Present NES100 Toxicity Study at Major Toxicology Conference

March 11, 2025March 10, 2025 - by Timothy Alexander

BERWYN, PA — Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) has announced that findings from its dose range toxicity study for NES100, an innovative intranasal peptide for managing acute and chronic non-cancer pain, …

Virpax Pharmaceuticals to Present NES100 Toxicity Study at Major Toxicology Conference Read More

Posts pagination

Previous 1 … 21 22 23 … 28 Next

Trending News

  • Education Department Rolls Out Broad Higher-Ed, Title IX Crackdown

  • Pennsylvania Teacher of the Year Lands in National Teacher of the Year Finals

  • CMS Blitz Targets Drug Prices, Medicaid Integrity, And U.S.-Made Supplies

  • State Pumps $1.2M Into Recovery Housing for Young Adults in 14 Counties

  • VA Announces Record $4.8 Billion Hospital Repair Surge as Top Aide Departs

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Department of Drug and Alcohol Programs

State Pumps $1.2M Into Recovery Housing for Young Adults in 14 Counties

8 hours agoFebruary 1, 2026

Department of Military and Veterans Affairs

VA Announces Record $4.8 Billion Hospital Repair Surge as Top Aide Departs

9 hours agoJanuary 31, 2026

Suspected cocaine

High-Speed Chase Ends in Struggle, Suspected Cocaine Tossed, Police Say

9 hours ago11 hours ago

Copyright © 2026 MyChesCo.